PALMERI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 1.266
EU - Europa 618
AS - Asia 158
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.045
Nazione #
US - Stati Uniti d'America 1.266
CN - Cina 139
IT - Italia 137
FI - Finlandia 130
UA - Ucraina 126
DE - Germania 87
GB - Regno Unito 33
IE - Irlanda 29
RO - Romania 18
BE - Belgio 17
SE - Svezia 14
RU - Federazione Russa 13
IN - India 12
FR - Francia 7
ES - Italia 4
IR - Iran 4
CL - Cile 2
AT - Austria 1
EU - Europa 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
KR - Corea 1
NL - Olanda 1
Totale 2.045
Città #
Fairfield 154
Ashburn 136
Chandler 125
Woodbridge 117
Ann Arbor 101
Jacksonville 72
Houston 68
Wilmington 68
Des Moines 59
Seattle 53
Cambridge 51
Medford 31
Dublin 29
Nanjing 26
Palermo 26
Altamura 21
Princeton 19
Brussels 17
Beijing 16
Boardman 15
Lawrence 14
Tulsa 13
Dearborn 12
Jinan 12
Nanchang 12
Changsha 11
Washington 11
Jiaxing 10
Shenyang 10
Kumar 9
San Diego 8
Tianjin 8
Hebei 7
New York 7
Zhengzhou 6
Ludwigshafen am Rhein 5
Verona 5
Albacete 4
Cagliari 4
Falls Church 4
Tehran 4
Ningbo 3
Norwalk 3
Rome 3
San Paolo di Civitate 3
Hangzhou 2
Kilburn 2
Kunming 2
Lanzhou 2
London 2
Phoenix 2
San Mateo 2
Taizhou 2
Torino 2
Venice 2
Auburn Hills 1
Bremen 1
Bristol 1
Central District 1
Chicago 1
Costa Mesa 1
Council Bluffs 1
Dallas 1
Durham 1
Fuzhou 1
Guangzhou 1
Haikou 1
Hanover 1
Hefei 1
Helsinki 1
Lecce 1
Levanto 1
Milan 1
Nanning 1
Orange 1
Prescot 1
Pune 1
Saint Petersburg 1
Santiago 1
Seongnam 1
Shanghai 1
Shaoxing 1
Taiyuan 1
Wageningen 1
Totale 1.441
Nome #
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 196
“Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma” 168
“Cytokine gene polymorphisms and breast cancer susceptibility” 153
“Weekly docetaxel and gemcitabine as first line treatment for metastatic breast cancer: results of a multicenter phase II study” 152
"Weekly docetaxel in the treatment of metastatic breast cancer" 146
Improved resolution power of electrophoretic fractionation of DNA using a voltage gradient up and down application 133
“Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site” 124
“High efficacy of the CHOP + Rituximab association in a case of primary rectal non Hodgkin lymphoma (NHL)” 119
Prognostic value of vascular endothelial growth factor (VEGF) and D-Dimer (DD) levels in cancer patients 109
"Should cirrhosis change our attitude towards treating non-hepatic cancer?" 107
“Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with metastatic (M) breast cancer (BC): results of an observational study” 94
“Serum HER-2/neu (s-HER2) levels evaluation in breast cancer (BC) patients (PTS)” 92
Weekly docetaxel (wDOC) for the treatment of metastatic breast cancer (MBC): A literature based meta-analysis 90
"Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with early (E) breast cancer (BC)” 78
“Final results of a phase II trial of a weekly (W) poly-chemotherapy (CT) with cisplatin (CDDP), epirubicin (EPI), fluorouracil (5FU), folinic acid (FA) and G-CSF for the treatment of gastroesophageal (GE) and gastric (G) cancer (C)” 71
“Role of loco-regional treatments for patients with breast cancer liver metastases” 68
“Results of a phase II study of a weekly regimen of cisplatin (CDDP),epirubicin (EPI), fluorouracil (5FU) and folinic acid (FA) with G-CSF in gastroesophageal (GE) and gastric (G) cancer” 64
GASTRIC CANCER (GC) ADJUVANT (A) CHEMOTHERAPY (CT): A LITERATURE BASED META-ANALYSIS (MA) 64
CISPLATIN (C) AND ALIMTA (A) WITH PANITUMUMAB FOR ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NS-NSCLC): A PHASE I-DOSE FINDING STUDY. 42
Totale 2.070
Categoria #
all - tutte 6.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019108 0 0 0 0 0 0 0 0 0 16 41 51
2019/2020523 59 14 40 35 59 57 51 31 56 24 67 30
2020/2021238 8 27 7 25 33 5 21 10 41 16 24 21
2021/2022203 10 56 1 5 9 9 12 10 28 15 7 41
2022/2023355 42 61 6 30 43 59 48 23 28 1 4 10
2023/2024153 11 17 6 30 23 32 11 23 0 0 0 0
Totale 2.070